Literature DB >> 17312668

Dermatologic correlates of selected metabolic events.

J B Cohen1, C K Janniger, Z Piela, J C Szepietowski, J A Samady, R A Schwartz.   

Abstract

Various metabolic events may lead to dermatologic pathology. Three illustrative examples are glucagonoma syndrome, uremic pruritus, and zinc deficiency. The glucagonoma syndrome, resulting from a glucagon secreting-tumor, is characterized by a distinctive dermatitis, necrolytic migratory erythema. This skin rash is a generalized, pruritic eruption which first appears as erythematous patches, then progresses to form superficial vesicles and bullae. Uremic pruritus is a clinical phenomenon seen in patients with chronic renal failure; it provokes vigorous scratching and may lead to numerous cutaneous lesions including extensive excoriations, lichen simplex chronicus, prurigo nodularis, keratotic papules, or secondary impetigo. Zinc deficiency may be evident as an inherited disease called acrodermatitis enteropathica, which presents clinically with a predominately acral and periorificial rash of sharply demarcated erythematous, exfoliative, and exudative patches. It may also result from an acquired defect with similar clinical findings. A brief review concerning the etiology, clinical manifestations, diagnosis, and treatment are given for glucagonoma syndrome, uremic pruritus, and zinc deficiency. Any pathophysiologic dysfunction that results in a loss of metabolic control of homeostasis in the body may demonstrate cutaneous manifestations. These skin findings may be of great clinical significance and may aid in the diagnosis or even be the first sign of a disease process. The glucagonoma syndrome, uremic pruritus, and zinc deficiency are three examples of dermatologic correlates of metabolic events.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 17312668

Source DB:  PubMed          Journal:  J Med        ISSN: 0025-7850


  2 in total

Review 1.  Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients.

Authors:  Ellie C Stefanadi; Georgios Dimitrakakis; Christos-Konstantinos Antoniou; Dimitrios Challoumas; Nikita Punjabi; Inetzi Aggeliki Dimitrakaki; Sangeeta Punjabi; Christodoulos I Stefanadis
Journal:  Diabetol Metab Syndr       Date:  2018-02-21       Impact factor: 3.320

2.  Targeted Metabolomics With Ultraperformance Liquid Chromatography-Mass Spectrometry (UPLC-MS) Highlights Metabolic Differences in Healthy and Atopic Staffordshire Bull Terriers Fed Two Different Diets, A Pilot Study.

Authors:  Robin Moore; Johanna Anturaniemi; Vidya Velagapudi; Jatin Nandania; Stella Maria Barrouin-Melo; Anna Hielm-Björkman
Journal:  Front Vet Sci       Date:  2020-10-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.